These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 9618074
1. Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus. Suzuki K, Ishida H, Takeshita N, Taguchi Y, Sugimoto C, Nosaka K, Seino Y. J Diabetes Complications; 1998; 12(3):176-80. PubMed ID: 9618074 [Abstract] [Full Text] [Related]
3. Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states. Nuche-Berenguer B, Moreno P, Esbrit P, Dapía S, Caeiro JR, Cancelas J, Haro-Mora JJ, Villanueva-Peñacarrillo ML. Calcif Tissue Int; 2009 Jun; 84(6):453-61. PubMed ID: 19219381 [Abstract] [Full Text] [Related]
4. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density. Suzuki K, Kurose T, Takizawa M, Maruyama M, Ushikawa K, Kikuyama M, Sugimoto C, Seino Y, Nagamatsu S, Ishida H. Diabetes Res Clin Pract; 2005 May; 68(2):117-25. PubMed ID: 15860239 [Abstract] [Full Text] [Related]
5. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Rissanen JP, Suominen MI, Peng Z, Halleen JM. Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692 [Abstract] [Full Text] [Related]
7. Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. Sosa M, Dominguez M, Navarro MC, Segarra MC, Hernández D, de Pablos P, Betancor P. J Diabetes Complications; 1996 Feb; 10(4):201-5. PubMed ID: 8835919 [Abstract] [Full Text] [Related]
8. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Hie M, Shimono M, Fujii K, Tsukamoto I. Bone; 2007 Dec; 41(6):1045-50. PubMed ID: 17916452 [Abstract] [Full Text] [Related]
10. Increased bone resorption may play a crucial role in the occurrence of osteopenia in patients with type 2 diabetes: Possible involvement of accelerated polyol pathway in its pathogenesis. Takizawa M, Suzuki K, Matsubayashi T, Kikuyama M, Suzuki H, Takahashi K, Katsuta H, Mitsuhashi J, Nishida S, Yamaguchi S, Yoshimoto K, Itagaki E, Ishida H. Diabetes Res Clin Pract; 2008 Oct; 82(1):119-26. PubMed ID: 18774197 [Abstract] [Full Text] [Related]
14. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker]. Nowak Z, Konieczna M, Saracyn M, Wańkowicz Z. Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372 [Abstract] [Full Text] [Related]
15. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide. Tähtelä R, Seppänen J, Laitinen K, Katajamäki A, Risteli J, Välimäki MJ. Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190 [Abstract] [Full Text] [Related]
17. Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium. Ylipahkala H, Halleen JM, Kaija H, Vihko P, Väänänen HK. Biochem Biophys Res Commun; 2003 Aug 22; 308(2):320-4. PubMed ID: 12901871 [Abstract] [Full Text] [Related]
20. Appliance-induced osteopenia of dentoalveolar bone in the rat: effect of reduced bone strains on serum bone markers and the multifunctional hormone leptin. Vinoth JK, Patel KJ, Lih WS, Seow YS, Cao T, Meikle MC. Eur J Oral Sci; 2013 Dec 22; 121(6):517-24. PubMed ID: 24112221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]